NSCLC: Bemcentinib + anti-PD1 triple PFS Bergen Bio ASA’s Axl kinase blocker bemcentinib in combination with MSD’s pembrolizumab has met the primary endpoint in a Phase II study in patients with non small cell lung cancer (NSCLC). more ➔
Transposase makes CAR-T production cheaperGerman researchers have designed a modified Sleeping Beauty transposase that can be used for non-viral, stable and efficient gene insertions for gene and CAR-T therapies. more ➔
Test detects breast cancer in earliest stageBreast cancer might be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced by tumour cells. more ➔
Sherlock Bioscience and Mologic enter partnership Synbio specialist Sherlock Biosciences and next-generation lateral flow testing expert Mologic Ltd have joined forces to develop a no-instrument rapid testing platform detecting virtually every infectious … more ➔
Protein protects against liver fibrosisGerman researchers have shown that a protein protects against the development of liver fibrosis by shutting down inflammatory signalling in liver stellate cells of the liver. more ➔
bit bio restarts with new management Cell reprogramming specialist bit bio has expanded its management with renowned experts in the field. more ➔
BioVersys receives up to €8m from CARB-XSwiss biotech company BioVersys AG has received a €8m grant by US-based non-profit organisation CARB-X to develop novel anti-virulence antibiotics to treat severe bacterial infections. more ➔
Researchers identify viral inflammation switchA team of Japanese and German researchers has found the protein that helps activate the inflammasome following viral invasion. more ➔
Rotavirus vaccines kill cancer cells Researchers at University Lyon have found a potential repurposing application of two market-approved rotavirus vaccines. more ➔
Polyphor presents AMR breakerSwiss Polyphor AG and researchers from the University of Zurich have presented the mechanism of action of a new class of antibiotics. more ➔
